CERT Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Certara

Certara to Participate in Upcoming Investor Conferences

3 days ago - By: Certara

Certara to Participate in Upcoming Investor Conferences

3 days ago - By: Certara

Certara Expands Biosimulation Market with AI-Driven QSP Platform

3 days ago - By: Certara

Certara Expands Biosimulation Market with AI-Driven QSP Platform

3 days ago - By: Zacks Investment Research - Mentions: ALEC

Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for

a month ago - By: Benzinga

Beyond The Numbers: 4 Analysts Discuss Certara Stock

14 days ago - By: Certara

Certara Scientists are Among the Topmost Cited Biopharma Researchers

14 days ago - By: Certara

Certara Scientists are Among the Topmost Cited Biopharma Researchers

24 days ago - By: Certara

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

24 days ago - By: Certara

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

3 months ago - By: Certara

Certara Reports Second Quarter 2025 Financial Results

3 months ago - By: Benzinga - Mentions: OEC VTLE DIN INSE ...

Earnings Scheduled For August 6, 2025

a month ago - By: Zacks Investment Research - Mentions: DOCS GEHC

Can Doximity's New AI Suite Drive the Growth It Needs?

2 months ago - By: Certara

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

2 months ago - By: Certara

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

2 months ago - By: Certara

Certara to Participate in Upcoming Investor Conferences

2 months ago - By: Certara

Certara to Participate in Upcoming Investor Conferences

3 months ago - By: The Motley Fool

Certara (CERT) Q2 Revenue Jumps 12%

3 months ago - By: Zacks Investment Research - Mentions: GLUE

Certara, Inc. (CERT) Q2 Earnings Miss Estimates

3 months ago - By: Certara

Certara Reports Second Quarter 2025 Financial Results

3 months ago - By: Certara

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

3 months ago - By: Certara

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

3 months ago - By: Certara

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

3 months ago - By: Certara

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

4 months ago - By: Yahoo Finance - Mentions: SLP CRL

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

4 months ago - By: Certara

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

4 months ago - By: Certara

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

4 months ago - By: Certara

Certara Announces Expansion of Clinical Technology Collaboration with Merck

4 months ago - By: Certara

Certara Announces Expansion of Clinical Technology Collaboration with Merck

4 months ago - By: Yahoo Finance - Mentions: BEAM INSP

10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

4 months ago - By: The Motley Fool - Mentions: TMDX PODD OPCH BEAM ...

10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

5 months ago - By: Zacks Investment Research - Mentions: DOCS GEHC

Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS?

6 months ago - By: Zacks Investment Research - Mentions: CLNN

CERTARA INC (CERT) Stock News

CERT Latest News, Press Relases and Analysis

Certara to Participate in Upcoming Investor Conferences

Certara to Participate in Upcoming Investor Conferences

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for

Beyond The Numbers: 4 Analysts Discuss Certara Stock

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Certara Reports Second Quarter 2025 Financial Results

Earnings Scheduled For August 6, 2025

Can Doximity's New AI Suite Drive the Growth It Needs?

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Certara to Participate in Upcoming Investor Conferences

Certara to Participate in Upcoming Investor Conferences

Certara (CERT) Q2 Revenue Jumps 12%

Certara, Inc. (CERT) Q2 Earnings Miss Estimates

Certara Reports Second Quarter 2025 Financial Results

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Simulations Plus Sees Weaker Demand Persist, Outlook Softens

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Certara Announces Expansion of Clinical Technology Collaboration with Merck

10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS?

Certara, Inc. (CERT) Q1 Earnings and Revenues Beat Estimates